- A new study in The Lancet found that SARS-CoV-2 can persist in the body for more than a year after infection. The study assessed the blood of 171 people who had Covid-19 and found proteins from the virus in 25% of the participants. “The fact that every new SARS-CoV-2 infection has the potential to become chronic is perhaps the single most concerning aspect of this virus,” said Polybio president Amy Proal. The study’s authors said SARS-CoV-2 persistence could contribute to Long Covid in adults and children.
- A clinical trial in Brentwood, Tennessee is looking for a Long Covid biomarker. The study will assess the blood RNA of 3,000 people with Long Covid and use artificial intelligence (AI) to see if it can identify RNA specific to patients with Long Covid, together and separately from controls. The study is recruiting in person in Tennessee, contact: justin@maxwellclinic.com
- Scientists may have found a significant overlap in the neurochemicals of Long Covid and myalgic encephalomyelitis (ME). The small study, published in the American Journal of Medicine, compared these markers in people with Long Covid, ME, and controls and found highly elevated Glutamate and N-acetyl-aspartate levels in both Long Covid and ME. The study’s authors wrote that the findings could suggest a potential overlap in the underlying pathology of ME and Long Covid and that the imbalanced neurochemicals may contribute to the complex symptoms experienced by both diseases.
Leave a Reply